Australia markets close in 2 hours 33 minutes

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.8100+0.0900 (+3.31%)
At close: 04:00PM EDT
2.8900 +0.08 (+2.85%)
After hours: 07:55PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts1111
Avg. Estimate-0.6-0.6-2.64-2.88
Low estimate-0.6-0.6-2.64-2.88
High estimate-0.6-0.6-2.64-2.88
Year ago EPS-0.84-0.72-3.24-2.64
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts1111
Avg. Estimate580k750k2.56M7.51M
Low estimate580k750k2.56M7.51M
High estimate580k750k2.56M7.51M
Year ago sales237k930k1.62M2.56M
Sales growth (year/est)144.70%-19.40%58.00%193.40%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS-0.96-0.84-0.96-0.48
Actual EPS-0.84-0.72-0.72-0.84
Difference0.120.120.24-0.36
Surprise %12.50%14.30%25.00%-75.00%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-0.6-0.6-2.64-2.88
7 days ago-0.05-0.05-0.22-0.24
30 days ago-0.04-0.04-0.17-0.18
60 days ago-0.04-0.04-0.17-0.18
90 days ago00-0.3-0.07
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesEVOKIndustrySector(s)S&P 500
Current qtr.28.60%N/AN/AN/A
Next qtr.16.70%N/AN/AN/A
Current year18.50%N/AN/AN/A
Next year-9.10%N/AN/AN/A
Next 5 years (per annum)40.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A